AIM ImmunoTech Inc. — Director's Dealing 2015

Apr 21, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HEMISPHERX BIOPHARMA INC (HEB)
CIK: 0000946644
Period of Report: 2015-04-20

Reporting Person: Equels Thomas K. (Director, CFO, Vice Chairman, Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-04-20	Common Stock	P	100000	$0.2391	Acquired	1205444	Direct